Arvinas (ARVN) Net Margin Growth (1y) (2018 - 2026)
Arvinas (ARVN) Net Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,491.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Arvinas | 529.92 Mn | -84.98 Mn | - | -41,314.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41,314.00 |
| Dec 31, 2025 | -63,329.00 |
| Sep 30, 2025 | -3,572.00 |
| Jun 30, 2025 | -22,720.00 |
| Mar 31, 2025 | 31,822.00 |
| Dec 31, 2024 | -43,535.00 |
| Sep 30, 2024 | 13,664.00 |
| Jun 30, 2024 | 7,380.00 |
| Mar 31, 2024 | -2,569.00 |
| Dec 31, 2023 | 57,107.00 |
| Sep 30, 2023 | 598.00 |
| Jun 30, 2023 | 7,989.00 |
| Mar 31, 2023 | -1,805.00 |
| Dec 31, 2022 | -7,305.00 |
| Sep 30, 2022 | 31,256.00 |
| Jun 30, 2022 | 71,484.00 |
| Mar 31, 2022 | 51,489.00 |
| Dec 31, 2021 | 48,770.00 |
| Sep 30, 2021 | -6,380.00 |
| Jun 30, 2021 | -42,384.00 |